Literature DB >> 10832687

A devastating ocular pathogen: beta-streptococcus Group G.

D C Ritterband1, M K Shah, D J Buxton, M C Intal, D S Guthrie, J A Seedor.   

Abstract

PURPOSE: To report the clinical findings, treatment, and outcomes of four cases of beta-streptococcus Group G (BHS-G) ocular infection.
METHODS: The medical and microbiologic records of four cases of BHS-G ocular infection were retrospectively reviewed.
RESULTS: Two cases of BHS-G endophthalmitis and two cases of BHS-G keratitis were recorded. Three patients developed fulminant infection within 12 hours of the onset of symptoms. One patient's history was incomplete. One patient developed endophthalmitis from a contaminated donor button; another following cataract surgery. One developed keratitis in a keratoplasty suture tract; and another patient developed a corneal abscess after being struck with a tree branch. The patient with the contaminated donor button developed overwhelming endophthalmitis resulting in no light perception vision, severe pain, and evisceration. The postoperative cataract patient developed a purulent endophthalmitis and is still hypotonus with light perception vision. The second keratitis patient developed a significant suture abscess with marked stromal loss but eventually healed. The traumatic keratitis patient developed a large ulcer with hypopyon and descemetocele but was lost to follow-up.
CONCLUSIONS: This is the first report of a series of BHS-G ocular infections. The ocular infections were characterized by rapid onset, extreme inflammation, and--despite in vitro antibiotic sensitivity--a poor or sluggish response to antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832687     DOI: 10.1097/00003226-200005000-00008

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  1 in total

1.  Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection.

Authors:  Suleyman Kugu; Mehmet Sahin Sevim; Nilufer Zorlutuna Kaymak; Gurkan Erdogan; Baran Kandemir; Omer Kamil Dogan
Journal:  Clin Ophthalmol       Date:  2012-08-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.